https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accounts-payable https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accounts-receivable https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/accumulated-depreciation https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/aoci https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/basic-shares https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/capital-expenditures https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/common-stock-dividends-shares https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/common-stock-value https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/comprehensive-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/current-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/current-liabilities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-offering-costs https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-tax-assets-tax-deferred-expense-other https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/depreciation-and-amortization https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/diluted-shares https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/dividends-declared https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/effective-tax-rate https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/eps https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/eps-basic https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/foreign-pretax-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/form-d-other https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/general-and-administrative-expense https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/grants-receivable-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/income-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/income-taxes-paid https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-other https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-preferred https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-warrants https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/interest-expense-other https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/interest-income-other https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/investing-cash-flow https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/net-change-in-cash https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/net-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/number-of-operating-segments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-expenses https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-cost https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-liability https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-liability-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/other-current-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/other-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/other-noncurrent-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/payments-of-financing-costs https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/preferred-shares-facts https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/prepaid-expense-current https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/pretax-income https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/pretax-income-domestic https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-repurchase-of-equity https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/profit-loss https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/property-plant-equipment https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/public-float https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/research-and-development https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/retained-earnings https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/shares-authorized https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/shares-issued https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/short-term-investments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-based-compensation https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/stock-split-ratio https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/temporary-equity-aggregate-amount-of-redemption-requirement https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/total-assets https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/total-liabilities https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/entasis-therapeutics-holdings-inc/weighted-average-number-of-share-outstanding-basic-and-diluted